683 Capital Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.6M | Sell |
445,000
-55,000
| -11% | -$3.04M | 1.62% | 9 |
|
|
2025
Q1 | $24.2M | Buy |
500,000
+90,000
| +22% | +$4.35M | 1.67% | 10 |
|
|
2024
Q4 | $15.8M | Sell |
410,000
-10,000
| -2% | -$386K | 0.98% | 17 |
|
|
2024
Q3 | $18.9M | Sell |
420,000
-184,449
| -31% | -$8.3M | 1.44% | 18 |
|
|
2024
Q2 | $20.9M | Sell |
604,449
-95,551
| -14% | -$3.31M | 1.58% | 13 |
|
|
2024
Q1 | $20.3M | Sell |
700,000
-15,000
| -2% | -$434K | 1.48% | 15 |
|
|
2023
Q4 | $16.4M | Sell |
715,000
-17,784
| -2% | -$408K | 1.34% | 21 |
|
|
2023
Q3 | $12.2M | Sell |
732,784
-81,216
| -10% | -$1.35M | 0.95% | 27 |
|
|
2023
Q2 | $22.5M | Buy |
814,000
+23,000
| +3% | +$635K | 1.61% | 15 |
|
|
2023
Q1 | $18.2M | Buy |
791,000
+583,200
| +281% | +$13.4M | 1.36% | 20 |
|
|
2022
Q4 | $2.27M | Buy |
+207,800
| New | +$2.27M | 0.19% | 88 |
|